alpha-aminopyridine has been researched along with B-Cell Lymphoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JJ; Gu, JJ; Guo, WJ; Li, R; Li, XY; Liu, YZ; Sun, XJ; Wang, L; Wu, JC; Xu, CH; Xue, K; Zhang, JY; Zhang, QL | 1 |
| Bashari, MH; Hernowo, BS; Ridwansyah, H; Sundawa Kartamihardja, AH; Wijaya, I | 1 |
| Higashi, M; Kizaki, M; Momose, S; Rosenwald, A; Sagawa, M; Sawada, K; Tabayashi, T; Tamaru, JI; Tanaka, Y; Tokuhira, M; Yamashita, T | 1 |
| Beauchamp, E; Berthiaume, LG; Dong, WF; Gamma, JM; Gray, DW; Iyer, A; Lakshmanan, M; Lim, ST; Mackey, JR; Perinpanayagam, MA; Postovit, LM; Raju, A; Read, KD; Tan, SY; Tergaonkar, V; Vincent, KM; Wyatt, PG; Yap, MC | 1 |
| Huang, J; Li, Q; Li, Y; Ou, Y; Wu, Y | 1 |
| Ke, XY; Li, YY; Wang, J; Wang, YF | 1 |
| Esquivel, CO; Hatton, O; Krams, SM; Lambert, SL; Martinez, OM; Natkunam, Y; Phillips, LK; Vaysberg, M | 1 |
1 review(s) available for alpha-aminopyridine and B-Cell Lymphoma
| Article | Year |
|---|---|
The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review.
Topics: Aminopyridines; Antineoplastic Agents; Humans; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Tumor Microenvironment | 2023 |
6 other study(ies) available for alpha-aminopyridine and B-Cell Lymphoma
| Article | Year |
|---|---|
Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma.
Topics: Aminopyridines; Animals; Apoptosis; Autophagosomes; Autophagy; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Forkhead Box Protein O1; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, B-Cell; Male; Mice, Nude; Middle Aged; Neoplasm Proteins; Recurrence; Up-Regulation | 2021 |
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.
Topics: Aminopyridines; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D3; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, B-Cell; Mutation; Piperazines; Protein Kinase Inhibitors; Pyridines | 2020 |
Targeting N-myristoylation for therapy of B-cell lymphomas.
Topics: Acyltransferases; Adenine; Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dasatinib; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Lymphoma, B-Cell; Mice; Mice, SCID; Models, Biological; Myristic Acid; Piperidines; Pyrazoles; Pyrimidines; Receptors, Antigen, B-Cell; Signal Transduction; src-Family Kinases; Sulfonamides; Xenograft Model Antitumor Assays | 2020 |
Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy.
Topics: Aged; Aminopyridines; Antigens, CD20; Antineoplastic Agents; Benzamides; Cell Line; Gene Expression Regulation, Neoplastic; Humans; Immunologic Factors; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mutation; RNA, Messenger; Tumor Suppressor Protein p53; Up-Regulation | 2019 |
[Effect of chidamide on human B lymphoma cell lines and its mechanisms].
Topics: Aminopyridines; Apoptosis; Benzamides; Caspase 3; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase Inhibitors; Humans; Lymphoma, B-Cell | 2012 |
Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.
Topics: Aminopyridines; Animals; Apoptosis; B-Lymphocytes; Cell Cycle; Cell Line, Tumor; Enzyme Activation; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Intracellular Signaling Peptides and Proteins; Lymph Nodes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred NOD; Mice, SCID; Morpholines; Oxazines; Phosphatidylinositol 3-Kinases; Postoperative Complications; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; Syk Kinase; Transplantation, Heterologous | 2013 |